Buckbinder L, Crawford DT, Qi H, Ke HZ, Olson LM, Long KR, et al., Proline-rich tyrosine kinase 2 regulates osteoprogenitor cells and bone formation, and offers an anabolic treatment approach for osteoporosis. Proc. Natl. Acad. Sci. U. S. A. 25 , 10619-24, (2007)
Han S, Mistry A, Chang JS, Cunningham D, et al., Structural characterization of proline-rich tyrosine kinase 2 (PYK2) reveals a unique (DFG-out) conformation and enables inhibitor design. J. Biol. Chem. 19 , 13193-201, (2009)
Walker DP, Bi FC, Kalgutkar AS, Bauman JN, Zhao SX, et al., Trifluoromethylpyrimidine-based inhibitors of proline-rich tyrosine kinase 2 (PYK2): structure-activity relationships and strategies for the elimination of reactive metabolite formation. Bioorg. Med. Chem. Lett. 23 , 6071-77, (2008)
安全信息
GHS Symbol
Precautionary statements
P301+P310
P305+P351+P338
Signal word
Danger
Hazard statements
H319 Causes serious eye irritation 严重刺激眼睛
H301 Toxic if swallowed 吞食有毒
WGK Germany
3
Safety Statements
S26 In case of contact with eyes, rinse immediately with plenty of water and seek medical advice 眼睛接触后,立即用大量水冲洗并征求医生意见;
S45 In case of accident or if you feel unwell seek medical advice immediately (show the label where possible) 发生事故时或感觉不适时,立即求医(可能时出示标签);